SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is selling off to a new 52-week low despite a Q3 earnings beat and a modest guidance increase. Traders are debating whether the results show real progress, with concerns about grant-supported profit and competition in advanced driver-assistance technology weighing against bullish views on the companys cash position and valuation.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

GNRCs Q3 results and growing data-center business are the main focus, with the Amazon supply agreement and expanding backlog reinforcing optimism about demand for backup power from AI infrastructure. Reactions are mixed: bulls see a new growth driver, while skeptics point to guidance concerns and lower margins in the faster-growing commercial and industrial segment.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lillys quarterly earnings beat and raised revenue outlook, driven by strong demand for Mounjaro and Zepbound, are fueling the rally and record-high discussion. Traders are broadly bullish on GLP-1 growth, while some flag the rich valuation, lower profit guidance tied to acquisition-related charges, and weaker-than-expected Foundayo sales.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has broken out to fresh 52-week highs as traders position around BRIUMVIs sales momentum and the upcoming Q3 report, with subcutaneous BRIUMVI data also viewed as a potential growth catalyst. Buyout and short-squeeze speculation is adding to the excitement, though some traders argue the rally still needs to be justified by commercial results.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Traders are focused on the anticipated completion of Compass Pathways rolling NDA submission for COMP360, its investigational psilocybin therapy for treatment-resistant depression, and the potential for an expedited FDA review. Many expect the filing to be a catalyst, while others are frustrated by the delay and cautious about the share-price weakness and uncertainty around approval.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

A new 8-K detailing CEO Gregory Demopuloss performance-based option award is drawing attention, with traders viewing its stock-price-linked vesting conditions as aligning his incentives with future appreciation. The discussion also reflects broader optimism around YARTEMLEAs U.S. sales growth and the upcoming quarterly results, though those expectations remain unconfirmed.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Reports that Innodata cut roughly 550 roles in India, with additional cuts reported in the Philippines, have raised concern that a client project was scaled back and could weigh on revenue, especially given customer concentration. Traders are divided between seeing the cuts as routine project changes or AI-driven efficiency and fearing a major client loss; many are looking to the November 5 earnings update for clarification.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

A strong third-quarter earnings beat has driven Regeneron shares sharply higher, with traders citing growth from Dupixent and Eylea HD and the breakout to a new 52-week high. The reaction is largely bullish, though traders are debating whether the rally will hold or fade after the sharp move.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention after a sharp selloff and a break below key support, with traders linking pressure to expectations of higher rates as inflation and oil prices remain elevated. The community is also debating whether forced liquidations and selling alongside risk assets explain golds failure to act as a safe haven, while some investors view the decline as a buying opportunity.

FuelCell Energy, Inc. is an American clean energy technology company that delivers continuous, scalable baseload power for mission-critical applications globally. It engages in the development, design, production, construction, operation, and servicing of high-temperature fuel cells for clean electric power generation. The company’s fuel cell systems generate electricity directly at the point of use, enabling reliable, low-emission power for data centers, industrial facilities, utilities, and distributed generation customers. FuelCell Energy delivers commercially proven, modular, utility-scale systems backed by global fuel cell deployments approaching one gigawatt. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

CEO Jason Fews Bloomberg interview has drawn criticism for offering little detail on the manufacturing ramp and the delayed Texas data-center agreement, intensifying concerns about management transparency and execution. Some traders remain bullish on fuel-cell demand from AI data centers, while others point to the delays, steep share-price decline and high short interest as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$WULF keep an eye on the Ratepayer Protection Act. Through House committee and awaiting it to be brought to vote on House floor. Could have a meaningful impact here. If a hyperscaler has to pay for the incremental grid infrastructure required to connect a huge new load, an existing site with substantial power infrastructure becomes more valuable.

Joe Ross

LALyle

StockTwits for iOS

TeraWulf Inc

 keep an eye on the Ratepayer Protection Act. Through House committee and awaiting it to be brought to vote on House floor. Could have a meaningful impact here. If a hyperscaler has to pay for the incremental grid infrastructure required to connect a huge new load, an existing site with substantial power infrastructure becomes more valuable.

Aaron

@TurdFerguson2 we have been saying that about Terawulf for a long time now, but the street hasn&#39;t priced this in to our share price unfortunately.

StockTwits For Android 

 we have been saying that about Terawulf for a long time now, but the street hasn't priced this in to our share price unfortunately.